An oldie but a goodie from the Dhaka Alternative Rock scene...lyrics in English
Last edited:
🇧🇩 Bangladeshi Chill Thread (5 Viewers)
- Thread starter Bilal9
- Start date
Bangladesh Defense ForumAnother oldie but goodie...
Last edited:
Bangla meets Brazilian Bossa Nova
- Jan 25, 2024
- 111,083
- 353
- 1,000
Visit to GB, Pakistan..
Sangrila Skardu, Gilgit Baltistan..
Sangrila Skardu, Gilgit Baltistan..
- Jan 25, 2024
- 111,083
- 353
- 1,000
Attabad Lake, GB , Pakistan..
Cultural differences/similarities between Bangladesh and Pakistan
Bilal bhai, your post above should have been posted to "space program in Bangladesh' thread.BRAC Onnesha was the first Cubesat Nano Satellite made by Bangladeshi students and researchers and launched as a multinational endeavor headed by Kyushu University in Japan (funding outlay borne was $500000 for Bangladesh side). More are planned in the future.
BRAC Onnesha - Wikipedia
en.wikipedia.org
🇧🇩 - Space Program in Bangladesh
What does Bangladesh’s space research organisation really do? What does Bangladesh’s space research organisation really do? Visual: Teeni and Tuni India's recent moon landing success raised a lot of curiosity and interest in Bangladesh and Pakistan. The question many people raised was: "Why...
www.pkdefense.com
Thank you
Meet Nawar, a Bangladeshi researcher named in Forbes' '30 Under 30 Local Toronto'
Nabanita Nawar. Photo: LinkedIn
Nabanita Nawar, a Bangladeshi researcher and entrepreneur residing in Canada, has been featured on Forbes' "30 Under 30 Local Toronto.
This is the first-ever such list by Forbes, and Nabanita stands as the sole Bangladeshi representative.
Forbes on Wednesday revealed the names and achievements of the 30 accomplished individuals based in Toronto, Canada.
Forbes' website highlights Toronto as the bustling heart of Canada and the next Silicon Valley.
Who is Nabanita Nawar?
Dr Nabanita Nawar is the CEO and Co-Founder of HDAX Therapeutics. She has a PhD in medicinal chemistry, and BSc in biological chemistry from the University of Toronto.
Nawar has over eight years of experience in drug discovery, leadership, governance, and science policy.
Her capabilities earned her the "2022 Rising Star" distinction from the Ontario Institute for Cancer Research (OICR).
She also received the "Canadian Silver Medal" from the Chemical Institute of Canada.
Forbes' website mentions that HDAX Therapeutics is developing the first-ever therapy for peripheral neuropathy (PN). It affects over 30 million people worldwide.
PN patients suffer from nerve damage that causes sensation loss, immobility and even paralysis. At present, there is no existing treatment capable of slowing, or reversing the progression of this disease.
However, HDAX is on the path to potentially administer doses to patients as early as 2025.
Nawar, and her partner, Pimyupa Manaswiyoungkul, filed multiple patents and partnered with top cancer research clinics worldwide.
Based in Toronto, the company emerged from five years of academic research conducted at the University of Toronto. The company has successfully raised over $800,000 in funding.
- Dr Nabanita Nawar is the CEO of HDAX Therapeutics
- HDAX Therapeutics IS developing the first-ever treatment for peripheral neuropathy
Nabanita Nawar. Photo: LinkedIn
Nabanita Nawar, a Bangladeshi researcher and entrepreneur residing in Canada, has been featured on Forbes' "30 Under 30 Local Toronto.
This is the first-ever such list by Forbes, and Nabanita stands as the sole Bangladeshi representative.
Forbes on Wednesday revealed the names and achievements of the 30 accomplished individuals based in Toronto, Canada.
Forbes' website highlights Toronto as the bustling heart of Canada and the next Silicon Valley.
Who is Nabanita Nawar?
Dr Nabanita Nawar is the CEO and Co-Founder of HDAX Therapeutics. She has a PhD in medicinal chemistry, and BSc in biological chemistry from the University of Toronto.
Nawar has over eight years of experience in drug discovery, leadership, governance, and science policy.
Her capabilities earned her the "2022 Rising Star" distinction from the Ontario Institute for Cancer Research (OICR).
She also received the "Canadian Silver Medal" from the Chemical Institute of Canada.
Forbes' website mentions that HDAX Therapeutics is developing the first-ever therapy for peripheral neuropathy (PN). It affects over 30 million people worldwide.
PN patients suffer from nerve damage that causes sensation loss, immobility and even paralysis. At present, there is no existing treatment capable of slowing, or reversing the progression of this disease.
However, HDAX is on the path to potentially administer doses to patients as early as 2025.
Nawar, and her partner, Pimyupa Manaswiyoungkul, filed multiple patents and partnered with top cancer research clinics worldwide.
Based in Toronto, the company emerged from five years of academic research conducted at the University of Toronto. The company has successfully raised over $800,000 in funding.
Bangladeshi-born Sakib Jamal shines in Forbes 30 Under 30 list
This recognition follows Jamal's inclusion in the Forbes 30 Under 30 Asia 2023 list earlier this year
File image of Sakib Jamal. Photo: Collected
Bangladeshi-born Sakib Jamal has achieved a remarkable feat by being named in Forbes' prestigious 30 Under 30 list for 2024 in North America.
This annual compilation recognizes outstanding individuals under 30 who have demonstrated significant influence and promise across various sectors, including business, technology and the arts. Jamal earned his place in the Venture Capital category.
As the first employee at Crossbeam Ventures, Jamal has been instrumental in the firm's remarkable growth since joining in 2020. Forbes notes that his contributions have been pivotal in elevating the firm's assets to an impressive $280 million across two core funds.
Having directly participated in nine investments for Crossbeam Ventures and being the primary contact for 14 others, Jamal's expertise and dedication led to his second promotion within the company in June, where he now holds the position of vice president.
Educated at Cornell University and hailing from Bangladesh, Jamal holds a Bachelor of Arts/Science degree.
This recognition follows Jamal's inclusion in the Forbes 30 Under 30 Asia 2023 list earlier this year. Additionally, his accomplishments were acknowledged in Crain's New York Business 20 Under 20 list.
This recognition follows Jamal's inclusion in the Forbes 30 Under 30 Asia 2023 list earlier this year
File image of Sakib Jamal. Photo: Collected
Bangladeshi-born Sakib Jamal has achieved a remarkable feat by being named in Forbes' prestigious 30 Under 30 list for 2024 in North America.
This annual compilation recognizes outstanding individuals under 30 who have demonstrated significant influence and promise across various sectors, including business, technology and the arts. Jamal earned his place in the Venture Capital category.
As the first employee at Crossbeam Ventures, Jamal has been instrumental in the firm's remarkable growth since joining in 2020. Forbes notes that his contributions have been pivotal in elevating the firm's assets to an impressive $280 million across two core funds.
Having directly participated in nine investments for Crossbeam Ventures and being the primary contact for 14 others, Jamal's expertise and dedication led to his second promotion within the company in June, where he now holds the position of vice president.
Educated at Cornell University and hailing from Bangladesh, Jamal holds a Bachelor of Arts/Science degree.
This recognition follows Jamal's inclusion in the Forbes 30 Under 30 Asia 2023 list earlier this year. Additionally, his accomplishments were acknowledged in Crain's New York Business 20 Under 20 list.
@Bilal9
Isn't one of YouTube's original founders part-Bangladeshi? From what I recall, he was one of the co-founders but can't quite remember his name.
Isn't one of YouTube's original founders part-Bangladeshi? From what I recall, he was one of the co-founders but can't quite remember his name.
Explosive news as all properties, bank accounts and assets of former IGP and RAB commander Benazir Ahmed and his family members have been frozen.
Challenge raised for Foreigners control act implementation targeting illegal foreign workers.
